Catalog Number:
CPTC-APOB-1
Target Antigen:
Apolipoprotein B
Isotype:
IgG1
Species:
Mouse Monoclonal Antibody
Last Updated:
11/21/2023
Antigen Recognition(s):
Peptide, Endogenous
Result: Positive
The affinity and binding kinetics of CPTC-APOB-1 and APOB 100 native protein were measured using biolayer interferometry. CPTC-APOB-1 antibody was covalently immobilized on amine-reactive second-generation sensors. APOB 100 native protein, 16 nM, 4 nM and 1 nM was used as analyte. Buffer only and biosensors immobilized without antibody were used as references for background subtraction.
Result: Presumed Positive
Affinity and binding kinetics of CPTC-APOB-1 and Apolipoprotein B / Apo B (APOB 100) human protein was measured using surface plasmon resonance. CPTC-APOB-1 was captured onto a Series S Protein G biosensor chip. APOB 100 native protein, 64 nM, 16 nM, 4 nM, and 1 nM, was used as analyte. Binding data were double-referenced and analyzed globally using a 1:1 model. APOB 100 native protein bound non-specifically to the Protein G reference channel (Fc1). The NSB was ~ 90% of the signal observed on the active channel (Fc2).
Result: Positive
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Negative
This antibody is not suitable for use in an Immunohistochemistry format as described in SOP M-106.
Result: Positive
IP-WB performed with CPTC-APOB-1 antibody as capture antibody. Eluates were screened in WB using antibody CPTC-APOB-3 as detection antibody. CPTC-APOB-1 was able to pull down the native protein purified from human plasma and the protein in human plasma, however, does not show to be able to pull down the target in HepG2 lysate. APOB MW is 515 KDa.
Result: Negative
Immunofluorescence staining using CPTC-APOB-1 as primary antibody against HepG2 cells shows no localization of APOB protein.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Positive
Indirect ELISA using CPTC-APOB-1 as primary antibody against human Apolipoprotein B / Apo B (APOB 100) native protein.
Result: Negative
This antibody is not suitable for use in a Reverse Phase Protein Array format as described in SOP M-105.
Result: Positive
Western blot using CPTC-APOB-1 as primary antibody against human APOB 100 native protein (lane 2). Expected molecular weight - 516 kDa. Molecular weight standards are also included (lane 1).
Result: Positive
Western blot using CPTC-APOB-1 as primary antibody against COLO205 (lane 2), HCC-2998 (lane 3), HCT-116 (lane 4), HCT-15 (lane 5), HT-29 (lane 6), SW-620 (lane 7), CaCO2 (lane 8), Hep G2 (lane 9) whole cell lysates and human (lane 10), mouse (lane 11), bovine (lane 12), and rabbit (lane 13) plasma. Expected molecular weight – 516 kDa. Molecular weight standards are also included (lane 1). Human plasma is positive.
Catalog Number:
CPTC-APOB-2
Target Antigen:
Apolipoprotein B
Isotype:
IgG2a
Species:
Mouse Monoclonal Antibody
Last Updated:
11/21/2023
Antigen Recognition(s):
Peptide, Endogenous
Result: Positive
The affinity and binding kinetics of CPTC-APOB-2 and APOB 100 native protein were measured using biolayer interferometry. CPTC-APOB-2 antibody was covalently immobilized on amine-reactive second-generation sensors. APOB 100 native protein, 256 nM, 64 nM, 16 nM and 4 nM was used as analyte. Buffer only and biosensors immobilized without antibody were used as references for background subtraction.
Result: Presumed Positive
Affinity and binding kinetics of CPTC-APOB-2 and Apolipoprotein B / Apo B (APOB 100) human protein were measured using surface plasmon resonance. CPTC-APOB-2 was captured onto a Series S Protein G biosensor chip. APOB 100 native protein, 64 nM, 16 nM, 4 nM, and 1 nM, was used as analyte. Binding data were double-referenced and analyzed globally using a 1:1 model. Kinetic constant, Kd, is outside the limits that can be measured by the instrument due to non-specific binding of the native APOB 100 protein to the Protein G reference surface. Kinetic constants cannot be uniquely determined due to non-specific binding of the native APOB 100 protein to the Protein G reference surface.
Result: Positive
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Negative
This antibody is not suitable for use in an Immunohistochemistry format as described in SOP M-106.
Result: Positive
IP-WB performed with CPTC-APOB-2 antibody as capture antibody. Eluates were screened in WB using antibody CPTC-APOB-3 as detection antibody. CPTC-APOB-2 was able to pull down the native protein purified from human plasma, in HepG2 lysate and the protein in human plasma. APOB MW is 515 KDa.
Result: Negative
Immunofluorescence staining using CPTC-APOB-2 as primary antibody against HepG2 cells shows no localization of APOB protein.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Positive
Indirect ELISA using CPTC-APOB-2 as primary antibody against human Apolipoprotein B / Apo B (APOB 100) native protein.
Result: Negative
This antibody is not suitable for use in a Reverse Phase Protein Array format as described in SOP M-105.
Result: Presumed Positive (with additional bands)
Western blot using CPTC-APOB-2 as primary antibody against human APOB 100 native protein (lane 2). Expected molecular weight - 516 kDa. Molecular weight standards are also included (lane 1).
Result: Positive
Western blot using CPTC-APOB-2 as primary antibody against COLO205 (lane 2), HCC-2998 (lane 3), HCT-116 (lane 4), HCT-15 (lane 5), HT-29 (lane 6), SW-620 (lane 7), CaCO2 (lane 8), Hep G2 (lane 9) whole cell lysates and human (lane 10), mouse (lane 11), bovine (lane 12), and rabbit (lane 13) plasma. Expected molecular weight – 516 kDa. Molecular weight standards are also included (lane 1). HepG2 and human plasma are positive.
Catalog Number:
CPTC-APOB-3
Target Antigen:
Apolipoprotein B
Isotype:
IgG2a
Species:
Mouse Monoclonal Antibody
Last Updated:
11/21/2023
Antigen Recognition(s):
Peptide, Endogenous
Result: Positive
The affinity and binding kinetics of CPTC-APOB-3 and APOB 100 native protein were measured using biolayer interferometry. CPTC-APOB-3 antibody was covalently immobilized on amine-reactive second-generation sensors. APOB 100 native protein, 256 nM, 64 nM, 16 nM and 4 nM was used as analyte. Buffer only and biosensors immobilized without antibody were used for reference subtraction.
Result: Negative
Affinity and binding kinetics of CPTC-APOB-3 and Apolipoprotein B / Apo B (APOB 100) human protein were measured using surface plasmon resonance. CPTC-APOB-3 was captured onto a Series S Protein G biosensor chip. APOB 100 native protein, 64 nM, 16 nM, 4 nM, and 1 nM, was used as analyte. No binding was observed.
Result: Positive
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Negative
This antibody is not suitable for use in an Immunohistochemistry format as described in SOP M-106.
Result: Positive
IP-WB performed with CPTC-APOB-3 antibody as capture antibody. Eluates were screened in WB using antibody CPTC-APOB-3 as detection antibody. CPTC-APOB-3 was able to pull down the native protein purified from human plasma, in HepG2 lysate and the protein in human plasma. APOB MW is 515 KDa.
Result: Negative
Immunofluorescence staining using CPTC-APOB-3 as primary antibody against HepG2 cells shows no localization of APOB protein.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Positive
Indirect ELISA using CPTC-APOB-3 as primary antibody against human Apolipoprotein B / Apo B (APOB 100) native protein.
Result: Negative
This antibody is not suitable for use in a Reverse Phase Protein Array format as described in SOP M-105.
Result: Presumed Positive (with additional bands)
Western blot using CPTC-APOB-3 as primary antibody against human APOB 100 native protein (lane 2). Expected molecular weight - 516 kDa. Molecular weight standards are also included (lane 1).
Result: Positive
Western blot using CPTC-APOB-3 as primary antibody against COLO205 (lane 2), HCC-2998 (lane 3), HCT-116 (lane 4), HCT-15 (lane 5), HT-29 (lane 6), SW-620 (lane 7), CaCO2 (lane 8), Hep G2 (lane 9) whole cell lysates and human (lane 10), mouse (lane 11), bovine (lane 12), and rabbit (lane 13) plasma. Expected molecular weight – 516 kDa. Molecular weight standards are also included (lane 1). Hep G2 and human plasma are positive.
NCI Identification Number:
00507
Antigen Name:
Apolipoprotein B
CPTC Name:
CPTC-APOB
Aliases:
Apolipoprotein B; Apolipoprotein B (Including Ag(X) Antigen); Apolipoprotein B-100; Apolipoprotein B48; Apo B-100; ApoB-100; ApoB-48; LDLCQ4; FCHL2; FLDB
Function:
This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. APOB (Apolipoprotein B) is a Protein Coding gene. Diseases associated with APOB include Hypobetalipoproteinemia, Familial, 1 and Hypercholesterolemia, Familial, 2. Among its related pathways are Folate Metabolism and Activated TLR4 signalling. Gene Ontology (GO) annotations related to this gene include binding and heparin binding.Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor.
Chromosomal Localization:
2p24.1
Accession Number:
NP_000375.3
UniProt Accession Number:
P04114
DNA Source:
N/A
Immunogen:
Native Protein
Vector Name:
N/A
Extinction Coefficient:
Buffers:
Expressed Sequence:
MDPPRPALLALLALPALLLLLLAGARAEEEMLENVSLVCPKDAT RFKHL
RKYTYNYEAESSSGVPGTADSRSATRINCKVELEVPQLCSFILKTSQCTL
KEV YGFNPEGKALLKKTKNSEEFAAAMSRYELKLAIPEGKQVFLYPEKD
EPTYILNIKRGI ISALLVPPETEEAKQVLFLDTVYGNCSTHFTVKTRKG
NVATEISTERDLGQCDRFKPI RTGISPLALIKGMTRPLSTLISSSQSCQ
YTLDAKRKHVAEAICKEQHLFLPFSYKNKY GMVAQVTQTLKLEDTPKIN
SRFFGEGTKKMGLAFESTKSTSPPKQAEAVLKTLQELKK LTISEQNIQR
ANLFNKLVTELRGLSDEAVTSLLPQLIEVSSPITLQALVQCGQPQCST H
ILQWLKRVHANPLLIDVVTYLVALIPEPSAQQLREIFNMARDQRSRATLY
ALSHAVN NYHKTNPTGTQELLDIANYLMEQIQDDCTGDEDYTYLILRVI
GNMGQTMEQLTPELKS SILKCVQSTKPSLMIQKAAIQALRKMEPKDKDQ
EVLLQTFLDDASPGDKRLAAYLMLM RSPSQADINKIVQILPWEQNEQVK
NFVASHIANILNSEELDIQDLKKLVKEALKESQL PTVMDFRKFSRNYQL
YKSVSLPSLDPASAKIEGNLIFDPNNYLPKESMLKTTLTAFGF ASADLI
EIGLEGKGFEPTLEALFGKQGFFPDSVNKALYWVNGQVPDGVSKVLVDHF
GY TKDDKHEQDMVNGIMLSVEKLIKDLKSKEVPEARAYLRILGEELGFA
SLHDLQLLGKL LLMGARTLQGIPQMIGEVIRKGSKNDFFLHYIFMENAF
ELPTGAGLQLQISSSGVIAP GAKAGVKLEVANMQAELVAKPSVSVEFVT
NMGIIIPDFARSGVQMNTNFFHESGLEAH VALKAGKLKFIIPSPKRPVK
LLSGGNTLHLVSTTKTEVIPPLIENRQSWSVCKQVFPG LNYCTSGAYSN
ASSTDSASYYPLTGDTRLELELRPTGEIEQYSVSATYELQREDRALV DT
LKFVTQAEGAKQTEATMTFKYNRQSMTLSSEVQIPDFDVDLGTILRVNDE
STEGKT SYRLTLDIQNKKITEVALMGHLSCDTKEERKIKGVISIPRLQA
EARSEILAHWSPAKL LLQMDSSATAYGSTVSKRVAWHYDEEKIEFEWNT
GTNVDTKKMTSNFPVDLSDYPKSL HMYANRLLDHRVPQTDMTFRHVGSK
LIVAMSSWLQKASGSLPYTQTLQDHLNSLKEFN LQNMGLPDFHIPENLF
LKSDGRVKYTLNKNSLKIEIPLPFGGKSSRDLKMLETVRTPA LHFKSVG
FHLPSREFQVPTFTIPKLYQLQVPLLGVLDLSTNVYSNLYNWSASYSGGN
T STDHFSLRARYHMKADSVVDLLSYNVQGSGETTYDHKNTFTLSCDGSL
RHKFLDSNIK FSHVEKLGNNPVSKGLLIFDASSSWGPQMSASVHLDSKK
KQHLFVKEVKIDGQFRVSS FYAKGTYGLSCQRDPNTGRLNGESNLRFNS
SYLQGTNQITGRYEDGTLSLTSTSDLQS GIIKNTASLKYENYELTLKSD
TNGKYKNFATSNKMDMTFSKQNALLRSEYQADYESLR FFSLLSGSLNSH
GLELNADILGTDKINSGAHKATLRIGQDGISTSATTNLKCSLLVLE NEL
NAELGLSGASMKLTTNGRFREHNAKFSLDGKAALTELSLGSAYQAMILGV
DSKNI FNFKVSQEGLKLSNDMMGSYAEMKFDHTNSLNIAGLSLDFSSKL
DNIYSSDKFYKQTV NLQLQPYSLVTTLNSDLKYNALDLTNNGKLRLEPL
KLHVAGNLKGAYQNNEIKHIYAI SSAALSASYKADTVAKVQGVEFSHRL
NTDIAGLASAIDMSTNYNSDSLHFSNVFRSVM APFTMTIDAHTNGNGKL
ALWGEHTGQLYSKFLLKAEPLAFTFSHDYKGSTSHHLVSRK SISAALEH
KVSALLTPAEQTGTWKLKTQFNNNEYSQDLDAYNTKDKIGVELTGRTLAD
LTLLDSPIKVPLLLSEPINIIDALEMRDAVEKPQEFTIVAFVKYDKNQD
VHSINLPFF ETLQEYFERNRQTIIVVLENVQRNLKHINIDQFVRKYRAA
LGKLPQQANDYLNSFNWE RQVSHAKEKLTALTKKYRITENDIQIALDDA
KINFNEKLSQLQTYMIQFDQYIKDSYD LHDLKIAIANIIDEIIEKLKSL
DEHYHIRVNLVKTIHDLHLFIENIDFNKSGSSTASW IQNVDTKYQIRIQ
IQEKLQQLKRHIQNIDIQHLAGKLKQHIEAIDVRVLLDQLGTTIS FERI
NDILEHVKHFVINLIGDFEVAEKINAFRAKVHELIERYEVDQQIQVLMDK
LVEL AHQYKLKETIQKLSNVLQQVKIKDYFEKLVGFIDDAVKKLNELSF
KTFIEDVNKFLDM LIKKLKSFDYHQFVDETNDKIREVTQRLNGEIQALE
LPQKAEALKLFLEETKATVAVY LESLQDTKITLIINWLQEALSSASLAH
MKAKFRETLEDTRDRMYQMDIQQELQRYLSL VGQVYSTLVTYISDWWTL
AAKNLTDFAEQYSIQDWAKRMKALVEQGFTVPEIKTILGT MPAFEVSLQ
ALQKATFQTPDFIVPLTDLRIPSVQINFKDLKNIKIPSRFSTPEFTILN
TFHIPSFTIDFVEMKVKIIRTIDQMLNSELQWPVPDIYLRDLKVEDIPLA
RITLPDFR LPEIAIPEFIIPTLNLNDFQVPDLHIPEFQLPHISHTIEVP
TFGKLYSILKIQSPLFT LDANADIGNGTTSANEAGIAASITAKGESKLE
VLNFDFQANAQLSNPKINPLALKESV KFSSKYLRTEHGSEMLFFGNAIE
GKSNTVASLHTEKNTLELSNGVIVKINNQLTLDSN TKYFHKLNIPKLDF
SSQADLRNEIKTLLKAGHIAWTSSGKGSWKWACPRFSDEGTHES QISFT
IEGPLTSFGLSNKINSKHLRVNQNLVYESGSLNFSKLEIQSQVDSQHVGH
SVL TAKGMALFGEGKAEFTGRHDAHLNGKVIGTLKNSLFFSAQPFEITA
STNNEGNLKVRF PLRLTGKIDFLNNYALFLSPSAQQASWQVSARFNQYK
YNQNFSAGNNENIMEAHVGIN GEANLDFLNIPLTIPEMRLPYTIITTPP
LKDFSLWEKTGLKEFLKTTKQSFDLSVKAQ YKKNKHRHSITNPLAVLCE
FISQSIKSFDRHFEKNRNNALDFVTKSYNETKIKFDKYK AEKSHDELPR
TFQIPGYTVPVVNVEVSPFTIEMSAFGYVFPKAVSMPSFSILGSDVRV P
SYTLILPSLELPVLHVPRNLKLSLPDFKELCTISHIFIPAMGNITYDFSF
KSSVITL NTNAELFNQSDIVAHLLSSSSSVIDALQYKLEGTTRLTRKRG
LKLATALSLSNKFVEG SHNSTVSLTTKNMEVSVATTTKAQIPILRMNFK
QELNGNTKSKPTVSSSMEFKYDFNS SMLYSTAKGAVDHKLSLESLTSYF
SIESSTKGDVKGSVLSREYSGTIASEANTYLNSK STRSSVKLQGTSKID
DIWNLEVKENFAGEATLQRIYSLWEHSTKNHLQLEGLFFTNGE HTSKAT
LELSPWQMSALVQVHASQPSSFHDFPDLGQEVALNANTKNQKIRWKNEVR
IH SGSFQSQVELSNDQEKAHLDIAGSLEGHLRFLKNIILPVYDKSLWDF
LKLDVTTSIGR RQHLRVSTAFVYTKNPNGYSFSIPVKVLADKFIIPGLK
LNDLNSVLVMPTFHVPFTDL QVPSCKLDFREIQIYKKLRTSSFALNLPT
LPEVKFPEVDVLTKYSQPEDSLIPFFEIT VPESQLTVSQFTLPKSVSDG
IAALDLNAVANKIADFELPTIIVPEQTIEIPSIKFSVP AGIVIPSFQAL
TARFEVDSPVYNATWSASLKNKADYVETVLDSTCSSTVQFLEYELNV LG
THKIEDGTLASKTKGTFAHRDFSAEYEEDGKYEGLQEWEGKAHLNIKSPA
FTDLHL RYQKDKKGISTSAASPAVGTVGMDMDEDDDFSKWNFYYSPQSS
PDKKLTIFKTELRVR ESDEETQIKVNWEEEAASGLLTSLKDNVPKATGV
LYDYVNKYHWEHTGLTLREVSSKL RRNLQNNAEWVYQGAIRQIDDIDVR
FQKAASGTTGTYQEWKDKAQNLYQELLTQEGQA SFQGLKDNVFDGLVRV
TQEFHMKVKHLIDSLIDFLNFPRFQFPGKPGIYTREELCTMF IREVGTV
LSQVYSKVHNGSEILFSYFQDLVITLPFELRKHKLIDVISMYRELLKDLS
K EAQEVFKAIQSLKTTEVLRNLQDLLQFIFQLIEDNIKQLKEMKFTYLI
NYIQDEINTI FSDYIPYVFKLLKENLCLNLHKFNEFIQNELQEASQELQ
QIHQYIMALREEYFDPSIV GWTVKYYELEEKIVSLIKNLLVALKDFHSE
YIVSASNFTSQLSSQVEQFLHRNIQEYL SILTDPDGKGKEKIAELSATA
QEIIKSQAIATKKIISDYHQQFRYKLQDFSDQLSDYY EKFIAESKRLID
LSIQNYHTFLIYITELLKKLQSTTVMNPYMKLAPGELTIIL
Native Sequence:
Calculated Isoelectric Point:
Molecular Weight:
515544
Last Updated:
03/04/2022
No SOPs available.
Get it for free at Adobe.com